Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease

Yonsei Medical Journal

Volumn 49, Issue 5, 2008, Pages 714-718

  Lee, Taek Jin ^a   Kim, Ki Hwan ^b   Chun, Jin Kyong ^b   Kim, Dong Soo ^b  

^a CHA University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Kawasaki disease; Methotrexate; Resistance to immunoglobulin

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; IMMUNOGLOBULIN; METHOTREXATE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BODY TEMPERATURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEVER; HUMAN; LOW DRUG DOSE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN BLOOD LEVEL; RISK REDUCTION;

CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; METHOTREXATE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TREATMENT OUTCOME;

EID: 58149463216     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.5.714     Document Type: Article

References (17)

1. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8.
2. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7.
3. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9.
4. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/ Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17: 1144-8.
5. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9.
6. Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001;43: 211-7.
7. Lee MS, An SY, Jang GC, Kim DS. A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate. Yonsei Med J 2002;43:527-32.
8. Ahn SY, Kim DS. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand J Rheumatol 2005;34:136-9.
9. Han BK, Lee HS, Kil HR, Han HS, Lee JH, Chung YH. A study on clinical application of Harada's scoring method to Kawasaki disease: suggesting the revision of the criteria for IVIG treatment of KD in Korea. J Korean Pediatr Soc 1997;40:539-48.
10. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
11. Figueiredo F, Uhing RJ, Okonogi K, Gettys TW, Johnson SP, Adams DO, et al. Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression. J Biol Chem 1990;265:12317-23.
12. Snijdewint FG, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-9.
13. Riksen NP, Barrera P, van den Broek PH, van Riel PL, Smits P, Rongen GA. Methotrexate modulates the kinetics of adenosine in humans in vivo. Ann Rheum Dis 2006;65:465-70.
14. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988;48:247-51.
15. Maury CP, Salo E, Pelkonen P. Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med 1988;319:1670-1.
16. Rooney TW, Furst DE, Koehnke R, Burmeister L. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1993;20:1297-302.
17. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78.